MYD88 and familial pancreatic carcinoma: Whether through these or additional mechanisms, it remains evident from our experiments that myeloid MyD88 signaling restricts production of type I interferon in response to RT, thereby limiting adaptive immune control of tumors in pancreatic cancer.